Rel A/p65 is required for cytokine-induced myotube atrophy.
about
Translational studies in older men using testosterone to treat sarcopenia.C26 cancer-induced muscle wasting is IKKβ-dependent and NF-kappaB-independent.The Impact of Hyperthermia on Receptor-Mediated Interleukin-6 Regulation in Mouse Skeletal Muscle.A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.SS-31 attenuates TNF-α induced cytokine release from C2C12 myotubes.Expression of Muscle-Specific Ribosomal Protein L3-Like Impairs Myotube Growth.S100 and p65 expression are increased in the masseter muscle after botulinum toxin-A injection.TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction.Inhibition of Stat3 signaling ameliorates atrophy of the soleus muscles in mice lacking the vitamin D receptor.Nuclear factor-κB signalling and transcriptional regulation in skeletal muscle atrophy.Simulated microgravity decreases circulating iron in rats: role of inflammation-induced hepcidin upregulation.TNFα-mediated Hsd11b1 binding of NF-κB p65 is associated with suppression of 11β-HSD1 in muscle.Muscle growth in young horses: Effects of age, cytokines, and growth factors.Cancer cachexia-when proteasomal inhibition is not enough.In utero LPS exposure impairs preterm diaphragm contractility.Matrix Metalloproteinase Responsive Delivery of Myostatin Inhibitors.Time course of cigarette smoke-induced changes of systemic inflammation and muscle structure.
P2860
Q33957794-F3AD340D-6D4A-4EE8-B0D1-9D699DF486A7Q35086723-47B3EEAE-4206-4A97-8E85-7CA8C71CAB23Q35922698-FE014C14-8373-4F8E-894A-CF4CCE0755A8Q35925919-56BB2F1F-E7DB-4170-9BE3-372FEC95B135Q36017207-5A421080-C827-430E-B8DF-8E32032E5F68Q36932613-B8FF6134-D74A-4FF4-8E71-DAE6847347CDQ37211791-69F66A05-6725-4A2E-B7FF-2E95F4CC3F7EQ37516544-3DC7A8F0-91A6-40A3-A9FE-8BF721FBB1F2Q37604742-781F8FAA-1634-4EEB-91DA-34CF0285FDBDQ38030905-4E1B726A-A44A-4CD4-A43A-A687B00D8D40Q39020860-830528C8-0A91-4A94-B23E-53E4545333B2Q39766222-9AB75845-59CB-4267-86D6-7258461484FFQ40238514-ABAF078A-A78F-496E-8CDA-FD3194228F1FQ41852980-FBF46F4D-C90B-4813-8AE2-D29ED55B84CFQ47996428-FA375EAF-835E-41CE-BE0E-595F751F40C7Q48355436-44E9BF34-0DF0-4F8D-AA43-9068D763BF7EQ53495310-BB16C29B-C1FF-47BB-9DC6-0A7E2C38679D
P2860
Rel A/p65 is required for cytokine-induced myotube atrophy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Rel A/p65 is required for cytokine-induced myotube atrophy.
@ast
Rel A/p65 is required for cytokine-induced myotube atrophy.
@en
type
label
Rel A/p65 is required for cytokine-induced myotube atrophy.
@ast
Rel A/p65 is required for cytokine-induced myotube atrophy.
@en
prefLabel
Rel A/p65 is required for cytokine-induced myotube atrophy.
@ast
Rel A/p65 is required for cytokine-induced myotube atrophy.
@en
P2093
P2860
P1476
Rel A/p65 is required for cytokine-induced myotube atrophy.
@en
P2093
Chia-Ling Wu
Michael Gustin
Robert W Jackman
Susan C Kandarian
Takuo Yamaki
P2860
P304
P356
10.1152/AJPCELL.00111.2012
P577
2012-05-16T00:00:00Z